🇺🇸 FDA
Pipeline program

Duloxetine

IRB00238678

Phase 3 small_molecule completed

Quick answer

Duloxetine for Knee Osteoarthritis is a Phase 3 program (small_molecule) at Pacira BioSciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Pacira BioSciences
Indication
Knee Osteoarthritis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials